Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Bojadgieva
PO-0161 Treatment of Iron Overload With Deferasirox in the Patients With Thalassaemia Major
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Related publications
MRI Multicentre Prospective Survey in Thalassaemia Major Patients Treated With Deferasirox Versus Deferiprone and Desferrioxamine
British Journal of Haematology
Hematology
Deferasirox in MDS Patients With Transfusion-Caused Iron Overload—a Phase-Ii Study
Annals of Hematology
Medicine
Hematology
Patterns of Liver Iron Accumulation in Sickle Cell Disease and Thalassaemia Patients With Iron Overload
European Journal of Haematology
Medicine
Hematology
Early Iron Overload in Beta-Thalassaemia Major: When to Start Chelation Therapy?
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Deferasirox Improves Liver Fibrosis in Beta-Thalassaemia Major Patients. A Five-Year Longitudinal Study From a Single Thalassaemia Centre
British Journal of Haematology
Hematology
Quantitative Ultrasonic Analysis of Myocardium in Patients With Thalassemia Major and Iron Overload
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Deferasirox (Exjade®) Significantly Improves Cardiac T2* in Heavily Iron-Overloaded Patients With Β-Thalassemia Major
Annals of Hematology
Medicine
Hematology
Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence Inβ-Thalassemia and Myelodysplastic Syndrome Patients With Iron Overload Receiving Deferasirox: Results From the EPIC Clinical Trial
Anemia
Hematology
Cell Biology
Denatured H-Ferritin Subunit Is a Major Constituent of Haemosiderin in the Liver of Patients With Iron Overload
Gut
Gastroenterology
